[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f3wiz4nw4y5yJIONzjjYiPsimcg8kgVqo3he_Qwgq1ak":8,"$f36Vym4FjTEt83jv9o95ysVRogtk4bFRbdZ7QBbeo-vM":55,"$fZpJN5FGKcfKHQYEzoIIVvPZ2kgYTWfP7OLAOuNJFIp4":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67144,867297,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","祁志勇","聊城市第二人民医院","甲状腺乳腺外科","住院医师",178,0,"乳腺癌术后靶向药物使用：关键细节与实用指南","","https://ystcdn.venuertc.com/venue/AI/d6996af5-a7f3-4767-98d9-33d39437b34b.jpg","\u003Cdiv class=\"material-container\">\n  \u003Ch2 id=\"material_title\" class=\"material-main-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌术后靶向药物使用：关键细节与实用指南\u003C/h2>\n  \u003Cdiv class=\"material-section material-intro\">\n    \u003Cdiv class=\"material-bg-intro\">\n      \u003Cp>\n        说到曲妥珠单抗，这款常见的靶向药物在乳腺癌术后药物治疗领域有着不可替代的地位。它通过作用于细胞表面的HER2受体，被广泛用于提高治疗有效率和减少复发风险。今天，咱们要聊聊服用曲妥珠单抗期间必须知道的7个关键细节，包括用药方法、药物相互作用、不良反应、特殊人群注意事项以及储存技巧📋。掌握这些内容后，你用药更安心，也能为家人保驾护航。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-title material-bg1\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 药物成分和剂型：了解你手里的靶向药物\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>曲妥珠单抗（Trastuzumab）是一种重组人源化IgG1型单克隆抗体。\u003C/li>\n        \u003Cli>该药专门针对乳腺细胞表面的HER2蛋白进行作用。\u003C/li>\n        \u003Cli>常见剂型为注射用粉剂，规格有150mg、440mg/瓶，需溶解后静脉输注。\u003C/li>\n        \u003Cli>正确做法：药剂需医务人员在无菌条件下配制，家属无需自行操作。\u003C/li>\n        \u003Cli>临床上，首剂剂量通常较高，后续维持剂量按体重或标准剂量调整。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">💡\u003C/span>\n        剂型需要专业医务人员操作，切勿擅自保存或使用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-title material-bg2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药物作用机制：发挥“精准打击”效果\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>曲妥珠单抗通过靶向HER2受体，阻断细胞生长信号，减少异常增殖。\u003C/li>\n        \u003Cli>其机制不同于化疗，仅选中HER2过表达细胞。\u003C/li>\n        \u003Cli>数据表明，曲妥珠单抗辅助方案可使术后复发风险降低近50%（Slamon et al., 2011）。\u003C/li>\n        \u003Cli>正确做法：全程用药需严格监控疗程和反应，单次剂量必须遵循医生安排。\u003C/li>\n        \u003Cli>与化疗联合时有协同作用，但不能替代其他治疗方法。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">🎯\u003C/span>\n        曲妥珠单抗靶点明确，对正常细胞影响较小。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-title material-bg3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 具体用法用量：操作细节决定安全\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>药物需静脉输注，不能口服、皮下或肌内注射。\u003C/li>\n        \u003Cli>每次服用量按体重、疗程及具体方案调整，无通用剂量。\u003C/li>\n        \u003Cli>首剂需在医疗环境下严密观察，后续每3周一次维持。\u003C/li>\n        \u003Cli>案例参考：一位75岁患者，术后每3周接受360mg曲妥珠单抗，无明显不适。\u003C/li>\n        \u003Cli>正确做法：用药期间定期回院复查，遵循医嘱，不自行更改间隔或剂量。\u003C/li>\n        \u003Cli>连续疗程完整性很重要，漏服或提前停药会影响疗效。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">📅\u003C/span>\n        个体剂量≠固定剂量，一切以医生评估为准。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-title material-bg4\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用：合理配伍防隐患\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>曲妥珠单抗与多西他赛等化疗药可联合，但需分次给予。\u003C/li>\n        \u003Cli>部分心脏药物（如洋地黄类）和抗生素（如阿霉素）会与曲妥珠单抗产生药理冲突。\u003C/li>\n        \u003Cli>服用降压药、心脏药或其它抗肿瘤药时，必须主动告知医生。\u003C/li>\n        \u003Cli>不能与葡萄柚汁等影响肝酶的食物同用。\u003C/li>\n        \u003Cli>正确做法：就诊时主动递交全部用药清单，由医生判断能否同时服用。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">⚠️\u003C/span>\n        任何新药、保健品都需先咨询医生，避免药物冲突。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-title material-bg5\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 典型不良反应：及时识别与处理技巧\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>最常见副作用为短暂发热、寒战，部分患者有皮疹或疲乏。\u003C/li>\n        \u003Cli>心脏毒性、心力衰竭等严重反应发生率约1-4%（Piccart-Gebhart et al., 2005）。\u003C/li>\n        \u003Cli>极少数患者有过敏反应或呼吸困难。\u003C/li>\n        \u003Cli>出现不良反应时：暂停药物并及时就医，不自行处理。\u003C/li>\n        \u003Cli>案例经验：部分患者曾因心脏不适需调整用药，全程心脏监控不可或缺。\u003C/li>\n        \u003Cli>正确做法：治疗前后定期做心脏功能检测，出现异常及时反馈。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">🩺\u003C/span>\n        不良反应多可逆转，发现问题及时就医是关键。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-title material-bg6\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 特殊人群用药：老年患者与身体状况个体化调整\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>老年人（>65岁）用药原则为：剂量根据体重和肾、心脏功能调整。\u003C/li>\n        \u003Cli>孕妇、哺乳期妇女一般禁用或需严格权衡风险。\u003C/li>\n        \u003Cli>肝肾功能减退者需辅助检查，可能要减少剂量或延长间隔。\u003C/li>\n        \u003Cli>一位高龄患者通过个体化评估，每次用药后均做心脏筛查，未出现严重副作用。\u003C/li>\n        \u003Cli>正确做法：老年患者及特殊人群用药需全过程医生把关，不能盲目套用常规方案。\u003C/li>\n        \u003Cli>身体虚弱、营养不良等情况须提前告知医生。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">👵\u003C/span>\n        个体化用药是安全保障，绝对不可省略。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-title material-bg7\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存与用药漏服：细节决定疗效\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>未溶解的曲妥珠单抗应在2-8℃冷藏保存，避免阳光直射和冷冻。\u003C/li>\n        \u003Cli>配制后药液需在24小时内用完。\u003C/li>\n        \u003Cli>过期或变色的药瓶坚决不能继续使用。\u003C/li>\n        \u003Cli>漏服处理：立即联系医生，不可自行补服或提前加量。\u003C/li>\n        \u003Cli>紧急状况下按专业建议就医，所有处理都需在专业指导下完成。\u003C/li>\n        \u003Cli>用药期间注意带好复查单，保证信息完整。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">📦\u003C/span>\n        正确储存和按时用药，是维持疗效的底线要求。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-summary\">\n    \u003Cdiv class=\"material-bg-summary\">\n      \u003Ch2 class=\"material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结：安全用药，让疗效看得见\u003C/h2>\n      \u003Cul>\n        \u003Cli>\n          曲妥珠单抗作为HER2靶向药物，优势在疗效明确、副作用相对可控。\n        \u003C/li>\n        \u003Cli>\n          最重要警示：所有用药步骤需遵医嘱，细节决定疗效，盲目操作极易出现隐患。\n        \u003C/li>\n        \u003Cli>\n          定期复查、合理宣教和主动沟通，是每位患者和家属都必须做到的。\n        \u003C/li>\n        \u003Cli>\n          服用任何新药、补充剂、保健品，都必须提前与医生核实，避免药物冲突。\n        \u003C/li>\n        \u003Cli>\n          万一出现心脏不适或突发反应，应立即停止用药并就诊。\n        \u003C/li>\n        \u003Cli>\n          用药全过程要高度重视远期风险与阶段目标，安全始终排第一。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-emoji\">✅\u003C/span>\n        掌握这些关键技巧，你和家人就能更安心地面对靶向药物治疗过程。如果有困惑，建议及时咨询专业医生或药师，切勿自行更改方案。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-refs\">\n    \u003Ch2 class=\"material-title material-bg-ref\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Cul>\n      \u003Cli>\n        Slamon, D. J., Eiermann, W., Robert, N., Pienkowski, T., Martín, M., Press, M., et al. (2011). Adjuvant trastuzumab in HER2-positive breast cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 365(14), 1273-1283. \u003Ca href=\"https://doi.org/10.1056/NEJMoa0910383\" target=\"_blank\">doi:10.1056/NEJMoa0910383\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., et al. (2005). Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 353(16), 1659-1672. \u003Ca href=\"https://doi.org/10.1056/NEJMoa052306\" target=\"_blank\">doi:10.1056/NEJMoa052306\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Baselga, J., Cortés, J., Kim, S. B., et al. (2012). Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. \u003Cem>The New England Journal of Medicine\u003C/em>, 366(2), 109-119. \u003Ca href=\"https://doi.org/10.1056/NEJMoa1113216\" target=\"_blank\">doi:10.1056/NEJMoa1113216\u003C/a>\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-container {\n  max-width: 780px;\n  margin: 25px auto 40px auto;\n  background: #f6fbff;\n  border-radius: 18px;\n  box-shadow: 0 6px 18px rgba(110, 140, 180, 0.12), 0 1.5px 6px rgba(110, 140, 180, 0.10);\n  padding: 28px 30px 36px 30px;\n  font-family: \"Helvetica Neue\", Arial, \"Microsoft YaHei\", sans-serif;\n  color: #28364d;\n}\n.material-main-title {\n  font-size: 2.0em;\n  text-align: center;\n  margin-bottom: 38px;\n  font-weight: 700;\n  letter-spacing: 2px;\n  color: #2753ab;\n}\n.material-section {\n  margin-bottom: 36px;\n}\n.material-title {\n  font-size: 1.25em;\n  font-weight: 600;\n  margin-bottom: 18px;\n  text-shadow: 0 1px 3px rgba(51,63,102,0.05);\n  letter-spacing: 1px;\n  padding: 14px 16px;\n  border-radius: 8px;\n}\n.material-bg-intro {\n  background: linear-gradient(90deg,#e8f0fb 0%,#f6fbff 95%);\n  padding: 22px 22px 14px 18px;\n  border-radius: 12px;\n  margin-bottom: 8px;\n}\n.material-bg1 { background: linear-gradient(90deg, #d0e6fa  0%, #f5fcff 95%); }\n.material-bg2 { background: linear-gradient(90deg, #e3f2fd 0%, #f5fcff 95%); }\n.material-bg3 { background: linear-gradient(90deg, #e7f8ee 0%, #f5fcff 95%); }\n.material-bg4 { background: linear-gradient(90deg, #fbe7e8 0%, #f6fbff 93%); }\n.material-bg5 { background: linear-gradient(90deg, #fff5e5 0%, #f6fbff 95%); }\n.material-bg6 { background: linear-gradient(90deg, #f9e8fd 0%, #f6fbff 95%);}\n.material-bg7 { background: linear-gradient(90deg, #efefe6 0%, #f6fbff 95%);}\n.material-bg-summary {\n  background: linear-gradient(87deg, #d1eef4 0%, #fafafd 90%);\n  padding: 16px 28px 15px 18px;\n  border-radius: 12px;\n  margin-bottom: 8px;\n}\n.material-bg-ref {\n  background: linear-gradient(90deg, #e3eafc 0%, #f6fbff 85%);\n}\n.material-content {\n  font-size: 1.0em;\n  line-height: 1.95em;\n  padding-bottom: 5px;\n}\n.material-content ul {\n  margin: 6px 0 13px 0;\n  padding-left: 24px;\n}\n.material-content li {\n  padding-bottom: 7px;\n}\n.material-emoji {\n  font-size: 1.15em;\n  padding-right: 4px;\n  vertical-align: middle;\n}\n.material-summary {\n  margin-top: 42px;\n}\n.material-summary ul {\n  padding-left: 26px;\n  margin-bottom: 14px;\n}\n.material-refs {\n  margin-top: 26px;\n  font-size: 0.98em;\n}\n.material-refs ul {\n  margin: 0px 0 6px 0;\n  padding-left: 22px;\n}\n.material-refs li {\n  padding-bottom: 8px;\n}\n@media screen and (max-width: 680px) {\n  .material-container {\n    padding: 14px 4vw 16px 4vw;\n    max-width: 100%;\n  }\n  .material-main-title { font-size: 1.25em;}\n  .material-title { font-size: 1.07em;}\n}\n\u003C/style>\n","\u003Cdiv class=\"material-container\">\n  \u003Ch2 id=\"material_title\" class=\"material-main-title\" style=\"color:",532,"2025-09-24 15:14:39","曲妥珠单抗, 乳腺癌, 靶向药物, 用法用量, 不良反应, 药物相互作用, 特殊人群, 健康管理","了解乳腺癌术后使用曲妥珠单抗的关键细节，掌握专业建议和实用指南，确保安全用药，提高治疗效果，给患者及家属更多信心！","2025-09-29 11:02:32",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]